Appendix Table 4. Complication Rates of Carotid Endarterectomya
Study Reference |
Design |
Setting |
Source Population | Study Period |
Population Selection |
Total Population |
| N |
Characteristics |
Bratzler, 199647 |
Retrospective, observational study using
Medicare claims database and medical records |
8 hospitals in Oklahoma (OK) |
OK Medicare beneficiaries |
1993-1994 |
All CEA cases from the OK Medicare claims data; hospital
selection not specified; all surgeons performing CEA in the 8 study hospitals |
813 CEAs (774 patients) |
Median-73 yrs % White NR
% Female NR
26% DM 20% COPD 10% CHF 67% CHD 71% HTN 26% Smoke 98% had stenosis
>
60% |
Cebul, 199848 |
Retrospective, cohort study using Medicare
provider analysis and review files |
115 hospitals/478 surgeons in Ohio (OH) |
7/93-6/94 |
Random sample of 700 of 4,120 non-HMO
Medicare beneficiaries in OH (18 patients had no medical record; 4 had
stroke; 3 had bilateral carotid procedures during same hospitalization);
hospitals performing CEA in OH |
678 patients |
Mean-73.1 yrs 94% White 46% Female 26% DMB 16% COPD 9% CHF % CHD NR
71% HTN 31%b Smoke % stenosis NR |
Halm, 20037 Rockman, 200555 Halm, 200553 Press, 200654 |
Cross-sectional study based on medical record
review of in- and outpatient records |
4 university hospitals, 2 community hospitals
served by 67 surgeons | - |
1/97-12/98 |
Reviewed 2,365 of 2,390 CEAs based on
hospitals' databases. Cases excluded if re-operation, surgery combined with
other major procedure, no CEA performed or missing data.
Each hospital contributed 130-583 cases. |
2124 |
Mean-72 yrs 87% White 43% Female 29% DM 9% COPD 8% CHF % CHD NR
73% HTN % Smoke NR
96% had >50% stenosis |
Halm 200749 |
Retrospective, observational study using New
York State Medicare claims database and medical records | - |
1/98-6/99 |
Reviewed 10, 817 eligible cases (94.8%).
Excluded reoperations, CEA combined with CABG, or no CEA performed. 551
cases excluded because of missing data. |
9588 |
Mean-74.6 yrs 93% White 56% Male 30% DM 19% COPD 10% CHF 62% CHD |
VA-NSQIP
Samsa, 200246 |
Secondary analysis of VA NSQIP data |
132 VA medical centers |
Patients undergoing surgery at a VA medical
center |
1994-1995
1996-1997 |
94% of those available for assessment
included in database, most excluded because of multiple index operations; 5
of the 123 VAs assessed <80% of eligible cases.
All VA hospitals performing major surgery;
all surgeons performing surgery at VA hospitals. |
7,842 |
Mean-68 yrs 91% White 2% Female 17% DM 17% COPD 2% CHF % CHD NR
% HTN NR
% Smoke NR
% Stenosis NR |
Horner, 200245 |
Secondary analysis of data in VA NSQIP
examining differences in CEA outcomes by ethnic group |
132 VA Medical Centers |
Patients having CEA |
10/94-9/97 |
Limited to men having CEA |
6551 |
20% >75 yrs 91% White 0% Female 29% DM 12% COPD 2% CHF % CHD NR
% HTN NR
% Smoke NR
% Stenosis NR |
Karp, 199850 |
Retrospective, cross-sectional study |
Medicare beneficiaries who underwent CEA in Georgia |
1993 |
Excluded 35 cases due to missing data. |
1945 |
Mean-72.3 yrs 91% White 47% Female 22% DM 24% COPD 8% CHF % CHD NR
% HTN NR
% Smoke NR
69% >75% |
Kresowik, 200052 |
Retrospective, observational study using Medicare
database and medical records |
30 hospitals in Iowa |
Iowa Medicare beneficiaries |
1994 & 6/95 to 5/96 |
All CEA cases from the Iowa Medicare claims
database (Part A & B); all hospitals in Iowa performing CEA on Medicare
patients; all surgeons in Iowa performing CEA on Medicare patients |
2063 |
Median-74 yrs % White NR
40% Female % DM NR
% COPD NR
% CHF NR
% CHD NR
% HTN NR
% Smoke NR
% Stenosis NR |
Kresowik, 200151 |
Retrospective, observational study using Medicare database and medical records |
10 states |
Medicare beneficiaries |
6/95-5/96 |
Random sample of 10,561 from 28,083
procedures identified from the MEDPAR Part A claims. |
10,030 patients |
Mean-73.6 yrs % White NR
43% Female % DM NR
% COPD NR
% CHF NR
% CHD NR
% HTN NR
% Smoke NR
% Stenosis NR |
Kresowik, 200444 |
Retrospective, observational study using Medicare database and medical records |
10 states |
Medicare beneficiaries |
6/98-5/99 |
Random sample of procedures identified from
the MEDPAR Part A claims. |
9,945 patients |
Mean-NR
% White NR
43% Female % DM NR
% COPD NR
% CHF NR
% CHD NR
% HTN NR
% Smoke NR
% Stenosis NR |
Appendix Table 4, Continued
Study Reference |
Total Asymptomatic
Population |
30-day Stroke/Death Other Complications (Asymptomatic) |
Threats to Internal & External Validity |
Quality Rating |
N (% Total) |
Characteristics |
Bratzler, 199647 |
347 (43%) |
Not reported |
Overall=3.7%
High volume hospital (>100 cases/year) =
3.5% Low volume hospital=5.2% 3% HTN 2% wound hematoma 2% pneumonia |
Data collected from medical record and claims
database
Reviewer blinding not discussed
No comprehensive evaluation, outcomes determined
by coding or documentation in chart
Generalizability low, select population |
Good |
Cebul, 199848 |
167 (25%) |
Not reported |
2.4%
Hospital-specific stroke/death rates
inversely related to the number of procedures, ranging from 7.7% lowest
quartile to 2.5% highest quartile
Asymptomatic patients at higher-volume
hospitals (greater than median) had no strokes or death at 30 days compared
to 4.9% and 4.6% in lower volume hospitals. Outcomes did not differ
significantly by surgeon volume.
Undergoing surgery in a higher volume
hospital was associated with a 71% reduction in risk of stroke or death at 30
days, after adjusting for patient characteristics (OR=0.29 (o.12-0.69)). |
No assessment of patients, outcomes
determined from readmission data; study did not include outpatient visits
Predominantly white population |
Fair |
Halm, 20037 Rockman, 200555 Halm, 200553 Press, 200654 |
1413 (65%) |
Not reported |
Asymptomatic with no co-morbidities=1.28% Low comorbidity (1 cardiac risk factor) =
2.21% Moderate (2)=2.77% High (ESRD, severe disability or over 2 risk
factors)=5.56%
Mean complication rate across groups=2.6% |
Complication rates (especially CVA) are
underestimated by administrative database.
No assessment of patients by neurologist.
All hospitals in 1 region, may not be
generalizable. |
Good |
Halm 200749 |
72% |
Not reported |
Asymptomatic without high comorbidity=2.69% Asymptomatic with high comorbidity=7.13% |
Large number of cases excluded due to missing
data.
Complication rates (especially CVA) are
underestimated by administrative database.
No assessment of patients by neurologist.
All hospitals in 1 region, may not be
generalizable. |
Fair |
VA-NSQIP
Samsa, 200246 |
3,231 |
Not reported |
30-day death, CVA, MI Overall=2.4% 1994-95=2.7% 1996-97=2.2% |
Reviewer not blinded to treatment, hospital
course.
Loss to follow-up not discussed, although
likely very little.
No comprehensive exam by neurologist for
outcome assessment.
No discussion of hospital selection.
Other complications not listed.
Generalizability low select population (white
males). |
Good |
Horner, 200245 |
2852 (44%) |
20% >75 yrs 92% White 0% Female 28% DM 10% COPD 2% CHF % CHD NR % HTN NR % Smoke NR % Stenosis NR |
Stroke or death: 1.6% White 2.1% Black 2.2% Hispanic
Stroke, MI or death: 2.3% White 2.1% Black 3.2% Hispanic |
Little selection within VA (VA patients are a
selected subgroups of US population) |
Good |
Karp, 199850 |
972 (51%) |
Not reported |
Mortality=0.8% Mod/Severe Stroke=1.0% MI=0.8% Combined (above)=2.6% All Stroke=2.4%
Symptomatic patients: Mortality=1.7% Mod/Severe Stroke=2.7% MI=1.4% Combined (above)=5.8% All stroke=4.7%
Found statistically significant increase in
morbidity, mortality and less severe complications at hospitals performing <10
CEAs. |
No comprehensive exam by neurologist for
outcome assessment.
No discussion of hospital selection.
Generalizability low (all males, mostly
white). |
Fair |
Kresowik, 200052 |
671 (20% '94; 40% '95-96) |
Not reported |
Overall=3.4% 1994=3.8% 1995-96=3.3% |
Unclear when reports of outcomes were given
to hospitals & surgeons.
No comprehensive evaluation, depended on
medical records for outcomes.
Relied on claims database for readmissions
for stoke, death occurring after discharge.
Generalizability |
Good |
Kresowik, 200151 |
3120 (39%) |
Not reported |
Combined events 3.7% Mortality 1.1%
The combined event rate by state for
asymptomatic patients ranged from 2.3% to 6.7%. Mortality ranged from 0.5%
to 2.5%. Only 2 states significantly different from the mean. |
Missed nonfatal neurologic events occurring
after discharge that did not result in another hospitalization. |
Good |
Kresowik, 200444 |
4093 |
Not reported |
Combined events 3.8%
The combined event rate by state for
asymptomatic patients ranged from 1.4% to 6.0%. Only 3 states significantly
different from the mean. |
Missed nonfatal neurologic events occurring
after discharge that did not result in another hospitalization. |
Good |
a. Percentages
have been rounded. b. Past or present smoker.
NR = Not
Reported, CEA = carotid endarterectomy DM = diabetes mellitus, COPD = chronic
obstructive pulmonary disease, CHF = congestive heart failure, CHD = coronary
heart disease, HTN = hypertension, CVA = stroke, MI = myocardial infarction,
HMO = health maintenance organization, VA = Veterans affairs, NSQIP = National VA Surgical Quality Improvement Program, CVA
= cerebral vascular accident, CABG = coronary artery bypass graft, ESRD = end
stage renal disease, OR = odds ratio, MI = myocardial infarction, MEDPAR = Medicare Provider Analysis and Review
Return to Document
|